8-K ·Filed Apr 13, 2026

CHE

CHEMED CORP
NEUTRAL
Impact 5/10
Horizonweeks Processed5mo ago SEC0000019584-26-000008
8-K material event: Items 1.01
Actionable Insight • Neutral

The renewal maintains Chemed's existing credit capacity without immediate financial impact. Traders should monitor the company's leverage ratio as it will affect the interest rate spread. The expansion option provides future flexibility for potential acquisitions or capital needs.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CHE ▲ +23.77% at T+60d
NEUTRAL call ✓ call won +23.77% · α vs SPY +14.85% · entry $387.62 → $479.76
Entry anchored
Apr 10, 03:59 PM ET
via exchange tick
T+1d
-2.89%
call -2.89% · α -4.10%
$376.41
settled 6mo ago
T+5d
-0.48%
call -0.48% · α -3.77%
$385.77
settled 6mo ago
T+20d
+8.72%
call +8.72% · α +0.99%
$421.43
settled 5mo ago
T+60d
+23.77%
call +23.77% · α +14.85%
$479.76
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Chemed Corp renewed its $450 million revolving credit facility with a five-year term, including a $100 million sublimit for letters of credit. The facility features a floating interest rate based on SOFR plus a spread that varies with the company's leverage ratio, and includes an option to expand by an additional $250 million.

Key Financial Metrics

Deal Value
$450.0M
Deal Type
credit_facility

Key Facts

  • Chemed renewed its $450 million revolving credit facility with a five-year term
  • The facility includes a $100 million sublimit for letters of credit
  • Interest rate is based on SOFR plus a spread that varies with leverage ratio
  • The agreement includes an expansion feature allowing Chemed to increase its revolver by an additional $250 million

Financial Impact

The credit facility maintains Chemed's borrowing capacity at $450 million with potential to expand to $700 million

debtliquidity

Risk Factors

  • Interest costs will fluctuate with SOFR rates and the company's leverage ratio
  • The company has insider selling activity totaling $554K

Market Snapshot

Exchange
NYSE
Sector
Services-Home Health Care Services

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000019584-26-000008
Document: che-20260410x8k.htm0000019584-26-000008
Document: che-20260410xex99_1.htm0000019584-26-000008
Document: 0000019584-26-000008-index-headers.html0000019584-26-000008
Document: 0000019584-26-000008-index.html0000019584-26-000008
Document: 0000019584-26-000008.txt0000019584-26-000008
10 reports for CHE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CHE — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$541.34 $496.62▼ −8.26%▼ −9.57%$503.20 (−7.05%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$539.72 $515.17▼ −4.55%▼ −3.31%$503.20 (−6.77%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$539.72 $515.17▼ −4.55%▼ −3.31%$503.20 (−6.77%)
Jul 28, 2026
9w ago
Press Release
BULLISH ★ 7/10
$539.36 $548.56▲ +1.71%▼ −3.31%$503.20 (−6.70%)
May 18, 2026
19w ago
Press Release
NEUTRAL ★ 2/10
$441.62 $433.87▼ −1.75%▼ −3.34%$503.20 (+13.94%)
May 1, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$422.16 $422.84▲ +0.16%▼ −5.12%$503.20 (+19.20%)
Apr 23, 2026
23w ago
8-K
BULLISH ★ 7/10
$421.11 $441.55▲ +4.85%▲ +0.83%$503.20 (+19.49%)
Apr 23, 2026
23w ago
Press Release
MIXED ★ 6/10
$421.11 $441.55▲ +4.85%▲ +0.83%$503.20 (+19.49%)
Apr 13, 2026
24w ago
8-K
NEUTRAL ★ 5/10
$387.62 $421.43▲ +8.72%▲ +0.99%$503.20 (+29.82%)
Feb 25, 2026
31w ago
8-K
MIXED ★ 6/10
$396.63 $371.95▼ −6.22%▲ +0.18%$503.20 (+26.87%)
Showing 10 of 10

US Market Status

Market Open — Closes in 3h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access